Network News

X My Profile
View More Activity
2.7%  Q1 GDP    4.57%  avg. 30-year mortgage     9.5%  Unemployment

Big Pharma Likes Daschle as Health Secretary

According to Wall Street, Tom Daschle is a good choice to be the new secretary of the Department of Health and Human Services.

Shares of the big drugmakers -- Pfizer, Eli LIlly, Merck, GlaxoSmithKline and AstraZeneca -- are all trading up from their opening this morning.

The former senator from South Dakota and Senate majority leader has health-care experience.

So does his wife, Linda, writes The Post's Ceci Connelly on our 44 blog:

"[Tom] Daschle is not a registered lobbyist but a senior strategist at the law firm Alston & Bird, which has an array of health industry clients. Linda Daschle, a longtime lobbyist, has said she will set up her own niche firm, focused solely on transportation, going forward."

-- Frank Ahrens
The Ticker is Twittering!

By Frank Ahrens  |  December 11, 2008; 12:01 PM ET
Categories:  The Ticker  | Tags: Eli Lilly, GlaxoSmithKline, Merck, Pfizer, Tom Daschle  
Save & Share:  Send E-mail   Facebook   Twitter   Digg   Yahoo Buzz   Del.icio.us   StumbleUpon   Technorati   Google Buzz   Previous: Boeing Delays 787 Dreamliner -- Again
Next: Sen. Corker's Alternative Autos Bailout Plan

No comments have been posted to this entry.

The comments to this entry are closed.

 
 
RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company